Review of the Epilepsy, Including Its Causes, Symptoms, Biomarkers, and Management

Yash Srivastav *

Department of Pharmacy, Goel Institute of Pharmacy & Sciences (GIPS), Lucknow, Uttar Pradesh, India.

Akhandnath Prajapati

Department of Pharmacy, Goel Institute of Pharmacy & Sciences (GIPS), Lucknow, Uttar Pradesh, India.

Prachi Agrahari

Department of Pharmacy, Rameshwaram Institute of Technology and Management (RITM), Lucknow, Uttar Pradesh, India.

Madhaw Kumar

Department of Pharmacy, Goel Institute of Pharmacy & Sciences (GIPS), Lucknow, Uttar Pradesh, India.

*Author to whom correspondence should be addressed.


Abstract

Epilepsy is a long-term medical disorder that frequently causes unpredictable, unprovoked repeated seizures that have an impact on both physical and mental abilities. It is among the most prevalent neurological conditions. Greek term epilambanein, which is the root of the English word epilepsy, means "to be seized." Both the sickness and the one-time attack were meant by this. The word refers to the magical beliefs of the time, which led to the stigma associated with epilepsy because people with epilepsy were seen to be dirty or bad. A recent study found that nearly 90% of the 70 million epileptics worldwide live in developing countries. Genetic testing has expanded the possibility of figuring out the aetiology of different types of epilepsies. It needs some prior clinical application knowledge to complete this challenging endeavour. Genetic testing techniques include chromosome microarray analysis, karyotyping, single-gene testing, gene panel testing, whole exome sequencing, and whole genome sequencing. The allegedly first documented account of epilepsy, as it was then perceived and understood, may be found in one of the earliest Babylonian medical manuals, Sakikku (English translation: "All Diseases"), which dates from around 1050 BC. The pathogenesis, aetiology, treatment, biomarkers, and risk factors for epilepsy are reviewed in this review article.

Keywords: Epilepsy, history, causes, symptoms and signs, risk factors, pathophysiology, biomarkers and treatments


How to Cite

Srivastav , Y., Prajapati , A., Agrahari , P., & Kumar , M. (2023). Review of the Epilepsy, Including Its Causes, Symptoms, Biomarkers, and Management. Asian Journal of Research in Medical and Pharmaceutical Sciences, 12(4), 64–84. https://doi.org/10.9734/ajrimps/2023/v12i4232

Downloads

Download data is not yet available.

References

Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR. Estimation of the burden of active and life-time epilepsy: A meta-analytic approach. Epilepsia. 2010; 51(5):883–90.

Najm IM. Mapping brain networks in patients with focal epilepsy. Lancet Neurol [Internet]. 2018;17(4):295–7. Available:http://dx.doi.org/10.1016/S1474-4422(18)30090-5

Moshé SL, Perucca E, Ryvlin P, Tomson T. Epilepsy: New advances. Lancet. 2015; 385(9971):884–98.

Patel P, Moshé SL. The evolution of the concepts of seizures and epilepsy: What’s in a name? Epilepsia Open. 2020;5(1):22–35.

Salud OM de la. Programme for Neurological Diseases, World Health Organization; Global Campaign against Epilepsy, Programme for Neurological Diseases, Neuroscience (World Health Organization); International Bureau for Epilepsy, World Health Organization; Department of Me. Atlas Epilepsy Care World; World Heal Organ Geneva, Switzerland, 2005 [Internet]. 2005;12-1(9):1–29.

Beghi E. Addressing the burden of epilepsy: Many unmet needs. Pharmacol Res [Internet]. 2016;107:79–84. Available:http://dx.doi.org/10.1016/j.phrs.2016.03.003

Galanopoulou AS, Buckmaster PS, Staley KJ, Moshé SL, Perucca E, Engel J, et al. Identification of new epilepsy treatments: Issues in preclinical methodology. Epilepsia. 2012;53(3):571–82.

Fisher RS, Van Emde Boas W, Blume W, Elger C, Genton P, Lee P, et al. Response: Definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) [4]. Epilepsia. 2005;46(10):1701–2.

Berg, A. (2006). Epidemiologic aspects of epilepsy. In: The Treatment of Epilepsy, 4e (eds. E. Wyllie, A. Gupta and D. Lachhwani), 113. Philadelphia, PA: Lippincott, Williams & Wilkins. 2006;2006.

Cascino GD, Sirven JI, Tatum WO. Epilepsy, Second Edition. Epilepsy, Second Ed. 2021;1–511.

JW S. The epidemiology of epilepsy revisited; 2003.

Khang YH. Burden of noncommunicable diseases and national strategies to control them in Korea. J Prev Med Public Heal. 2013;46(4):155–64.

Aggarwal A, Mehta S, Gupta D, Sheikh S, Pallagatti S, Singh R, et al. Clinical & immunological erythematosus patients characteristics in systemic lupus Maryam. J Dent Educ [Internet]. 2012;76(11):1532–9. Available:http://www.ncbi.nlm.nih.gov/pubmed/23144490

Annapurna Poduri, Beth Rosen Sheidley, Sara Shostak and RO. Genetic testing in the epilepsies-developments and dilemmas. Brain Lang [Internet]. 2004;88(1):1–20. Available:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624763/pdf/nihms412728.pdf

Brodie MJ, Barry SJE, Bamagous GA, Norrie JD, Kwan P. Patterns of treatment response in newly diagnosed epilepsy. Neurology. 2012;78(20):1548–54.

Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, Van Emde Boas W, et al. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;51(4):676–85.

Hirtz DG, Thurman DJ, Gwinn-Hardy K, Zalutsky R. How common are the “common” neurologic disorders? [4]. Neurology. 2007;69(4):410–1.

Engel J. Classifications of the International League Against Epilepsy: Time for reappraisal. Epilepsia. 1998;39(9): 1014–7.

Penry K. Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic Seizures. Epilepsia. 1981;22(4): 489–501.

Scheffer, Ingrid E., et al. The organization of the epilepsies: report of the ILAE Commission on Classification and Terminology. ILAE websit. 2014;2014.

Oxford English Dictionary; 2004.

Rho, Jong M, Raman Sankar, Jose E. Cavazos, eds. Epilepsy: scientific foundations of clinical practice. CRC Press, 2004. 2004;2004.

Jilek-Aall L. Morbus sacer in Africa: Some religious aspects of epilepsy in traditional cultures. Epilepsia. 1999;40(3):382–6.

Magiorkinis E, Sidiropoulou K, Diamantis A. Hallmarks in the history of epilepsy: Epilepsy in antiquity. Epilepsy Behav. 2010;17(1):103–8.

Global Campaign Against Epilepsy Atlas Epilepsy Care in the World 2005. 2005;25.

Jacobs BA, Miller J. Crack dealing, gender, and arrest avoidance. Soc Probl. 1998; 45(4):550–69.

A Disease Once Sacred: A History of the Medical Understanding of Epilepsy - Mervyn J. Eadie, Peter F. Bladin - Google Books. 2001;2001.

Available:https://books.google.de/books?id=ZhNW0AJPAzgC&pg=PA215&lpg=PA215&dq=posttraumatic+epilepsy+history&redir_esc=y

WHO Epilepsy in the WHO Africa Region: Bridging the Gap: The global campaign Against Epilepsy: “ Out of the shadows ’’ Geneva WHO 2004. 2011; 2011.

Marieb EN. Human anatomy and physiology. New Delhi Pearson Education Inc and Dorling Kindersley Publishing Inc, 6th ed. 2006:430-88. 2006;2006.

Frucht MM, Quigg M, Schwaner C, Fountain NB. Distribution of seizure precipitants among epilepsy syndromes. Epilepsia [Internet]. 2000 Dec;41(12): 1534—1539. Available:https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1499-1654.2000.001534.x

Herzog AG, Harden CL, Liporace J, Pennell P, Schomer DL, Sperling M, et al. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Ann Neurol. 2004;56(3): 431–4.

Fauci, Anthony S., et al. Harrison’s: Principles of Internal Medicine. v. 2: il. New Youk: McGraw- Hill. 1998;1998.

Mattar EA. Application of Machine Learning for Electroencephalography Classification of University of Bahrain College of Engineering Department of Electrical and Electronics Engineering Application of Machine Learning for Electroencephalography Classification of Epi; 2022 May.

Yousefi MR, Dehghani A, Golnejad S, Hosseini MM. applied sciences Comparing EEG-Based Epilepsy Diagnosis Using Neural Networks and Wavelet Transform. 2023;1–14.

Buckland WW. A manual of Roman private law.

Ahmad I, Wang X, Zhu M, Wang C, Pi Y, Khan JA, et al. EEG-Based Epileptic Seizure Detection via Machine/Deep Learning Approaches: A Systematic Review. Comput Intell Neurosci. 2022; 2022.

Namazi H, Kulish V V., Hussaini J, Hussaini J, Delaviz A, Delaviz F, et al. A signal processing based analysis and prediction of seizure onset in patients with epilepsy. Oncotarget. 2016;7(1):342–50.

Fisher RS. The New Classification of Seizures by the International League Against Epilepsy 2017. Curr Neurol Neurosci Rep. 2017;17(6):1–6.

Thurman DJ, Beghi E, Begley CE, Berg AT, Buchhalter JR, Ding D, et al. Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia. 2011; 52(7):2–26.

Annuar RMHRK, Shahbudin S, Kassim M, Rahman FYA. Epilepsy Seizure Detection and Classification Analysis using Residual Neural Network. In: 2021 IEEE 11th International Conference on System Engineering and Technology (ICSET). 2021:347–51.

Viglione SS, Walsh GO. Proceedings: Epileptic seizure prediction. Electroencephalogr Clin Neurophysiol [Internet]. 1975 Oct;39(4):435-436.

Available:http://europepmc.org/abstract/MED/51767

KALMUS H. Biological Cybernetics. Nature. 1972;237(5349):55–6.

Valeta, Thalia, and Thalia Valeta. Epileptic Seizures. The Epilepsy Book: A Companion for Patients: Optimizing Diagnosis and Treatment. (2017):23-32. 2017;2017.

Altaf Z, Unar MA, Narejo S, Zaki MA, Naseer-u-Din. Generalized Epileptic Seizure Prediction using Machine Learning Method. Int J Adv Comput Sci Appl. 2023; 14(1):502–10.

Racine RJ. Modification of seizure activity by electrical stimulation: I. after-discharge threshold. Electroencephalogr Clin Neurophysiol. 1972;32(3):269–79.

Betts T. Do Seizures Damage the Brain. Seizure. 2004;13(5):362–3.

Meyer ML, Bloom PR, Grava J. Partial Epilepsy of Long Duration: Changing Semiology with Age Paolo. 1989;85(2):79–85.

Rubin PC. Controversies in Management: Commentary. Bmj. 1996;312(7022):40.

Sutula T, Harrison C, Steward O. Chronic epileptogenesis induced by kindling of the entorhinal cortex: the role of the dentate gyrus. Brain Res. 1986;385(2): 291–9.

Kelly ME, McIntyre DC. Hippocampal kindling protects several structures from the neuronal damage resulting from kainic acid-induced status epilepticus. Brain Res. 1994;634(2):245–56.

Lynch M, Sayin Ü, Bownds J, Janumpalli S, Sutula T. Long-term consequences of early postnatal seizures on hippocampal learning and plasticity. Eur J Neurosci. 2000;12(7):2252–64.

Pitkänen A, Nissinen J, Nairismägi J, Lukasiuk K, Gröhn OHJ, Miettinen R, et al. Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy. Prog Brain Res. 2002;135:67–83.

Kotloski R, Lynch M, Lauersdorf S, Sutula T. Repeated brief seizures induce progressive hippocampal neuron loss and memory deficits. Prog Brain Res. 2002; 135:95–110.

Sutula T, Lauersdorf S, Lynch M, Jurgella C, Woodard A. Deficits in radial arm maze performance in kindled rats: Evidence for long-lasting memory dysfunction induced by repeated brief seizures. J Neurosci. 1995;15(12):8295–301.

Dodrill CB. Progressive cognitive decline in adolescents and adults with epilepsy. Prog Brain Res. 2002;135(Box 359745):399–407.

Bernasconi A, Tasch E, Cendes F, Li LM, Arnold DL. Proton magnetic resonance spectroscopic imaging suggests progressive neuronal damage in human temporal lobe epilepsy. Prog Brain Res. 2002;135(1994):297–304.

Haruna A, Pateh UU, Sule MI, Musa AM, Sani YM, Mohammed M, et al. Evaluation of anticonvulsant activity of methanol leaf extract of Hymenocardia acida, Tul (Euphorbiaceae) in laboratory animals. J Pharm Allied Sci. 2017;14(5):2675–83.

Gidal BE, Garnett WR. Epilepsy. In: Dipiro J T, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: a pathophysiologic approach. USA: McGraw-Hill Companies Inc, 6th ed. 2005:1023-46. 2005;2005.

Meisler MH, Kearney JA. Sodium channel mutations in epilepsy and other neurological disorders. J Clin Invest. 2005; 115(8):2010–7.

Hastuti S, Idroes R, Imran I, Ramli Y, Abas AH, Tallei TE. hUMSC vs. hUMSC–Exosome: Which One Is Better for Epilepsy? Pharmaceuticals. 2022;15(10): 1–15.

Fisher RS, Cross JH, D’Souza C, French JA, Haut SR, Higurashi N, et al. Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia. 2017;58(4):531–42.

Lawson JA, Scheffer IE. Therapeutic use of medicinal cannabis in difficult to manage epilepsy. Br J Clin Pharmacol. 2018; 84(11):2488–90.

Dalic L, Cook MJ. Managing drug-resistant epilepsy: Challenges and solutions. Neuropsychiatr Dis Treat [Internet]. 2016;12:2605–16.

Available:https://doi.org/10.2147/NDT.S84852

Ghosal, Anujit, et al. “Nanotechnology for therapeutics.” Advances in Personalized Nanotherapeutics. 2017:25-40. 2017;2017.

Ryvlin P, Ciumas C, Wisniewski I, Beniczky S. Wearable devices for sudden unexpected death in epilepsy prevention. Epilepsia. 2018;59(December 2017):61–6.

Jerome Engel Jr1 AP. Biomarkers for epileptogenesis and Its treatment. Physiol Behav. 176(5):139–48.

Tiwari S, Sharma V, Mujawar M, Mishra YK, Kaushik A, Ghosal A. Biosensors for epilepsy management: State-of-art and future aspects. Sensors (Switzerland). 2019;19(7).

Beale, John M, JHB. Organic medicinal and pharmaceutical chemistry; 2011.

Mukhopadhyay HK,Kandar CC, Das SK, Ghosh LK GB. Epilepsy and its Management: A Review. J Pharma Sci Tech. 2012;1(2):20–6.

Rang HP, Dale MM, Ritter JM, Moore PK. Pharmacology. New Delhi: Churchill Livingstone Reed Elsevier India (P) Ltd, 5th ed. 2006:550-60. 2006;2006.

Ellenberg JH, Hirtz DG, Nelson KB. Do Seizures in Children Cause Intellectual Deterioration? N Engl J Med [Internet]. 1986;314(17):1085–8.

Available:https://doi.org/10.1056/NEJM198604243141705

Sinha YA, Bijauliya RK, et al. a Comparative Review on Epilepsy and Its Treatment Options. Curr Res Pharm Sci. 2022;12(1):12–8.

Williams A, Lee P, Kerr A. Scottish Intercollegiate Guidelines Network (SIGN) guidelines on tonsillectomy: A three cycle audit of clinical record keeping and adherence to national guidelines. J Laryngol & amp; Otol. 2002;116(6):453–454.

Stephen LJ, Brodie MJ. Special problems: Adults and elderly. Epilepsia. 2008;49(1): 45–9.

Bazil CW, Morrell MJ, Pedley TA. Epilepsy. In: Rowland LP, ed. Merritt’s Neurology, 1 1th ed. Philadelphia: Lippincott Williams & Wilkins. 2005;990 – 1008. 2005;2005.

Elwes RDC, Johnson AL, Shorvon SD, Reynolds EH. The Prognosis for Seizure Control in Newly Diagnosed Epilepsy. N Engl J Med [Internet]. 1984; 311(15):944–7.

Available:https://doi.org/10.1056/NEJM198410113111503

McNamara JO. Drugs effective in the therapy of the epilepsies. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, eds. Goodman & Gilman’s The Pharm acological Basis of Therapeutics, 9th ed. New York: McGraw-Hill; 1999;461–486. 1999;1999.

Stephen LJ, Brodie MJ. Selection of Antiepileptic Drugs in Adults. Neurol Clin. 2009;27(4):967–92.

Dulac O, Leppik IE, Chadwick DW, et al. Starting and stopping treatment. In: Engel J Jr, Pedley TA, eds. Epilepsy: A Comprehensive Textbook. 2008;2:2.

Goldenberg MM. Overview of drugs used for epilepsy and seizures: Etiology, diagnosis, and treatment. PT. 2010;35(7): 392–415.